A treatment apparatus which uses thermal or non-thermal plasma to treat urinary tract infections (UTIs) by destroying bacteria. The apparatus comprises an elongate probe that includes a coaxial cable for conveying radiofrequency (RF) electromagnetic (EM) energy and/or microwave EM energy, a probe tip connected at the distal end of the coaxial cable for receiving the RF and/or microwave EM energy, and a gas conduit for conveying gas to the probe tip. The probe tip comprises a first electrode connected to the inner conductor of the coaxial cable, and a second electrode connected to the outer conductor of the coaxial cable, and wherein the first electrode and second electrode are arranged to produce an electric field from the received RF and/or microwave EM energy across a flow path of gas received from the gas conduit to produce a thermal or a non-thermal plasma.

A healthy gas generating system for generating healthy gas for inhalation by a user includes an electrolysis device, a gas mixing device, and a backfire barrier. The electrolysis device electrolyzes water to generate a gas with hydrogen. The gas mixing device includes a mixer and a vibrator for mixing the combination gas with an atomized gas to produce the healthy gas. The backfire barrier is configured on the output of the gas mixing device or the gas passage of receiving the combination gas to avoid the backflow of the gas.

A healthy gas generating system for generating healthy gas for inhalation by a user includes an electrolysis device, a gas mixing device, and a backfire barrier. The electrolysis device electrolyzes water to generate a gas with hydrogen. The gas mixing device includes a mixer and a vibrator for mixing the combination gas with an atomized gas to produce the healthy gas. The backfire barrier is configured on the output of the gas mixing device or the gas passage of receiving the combination gas to avoid the backflow of the gas.

Proposed is a portable gas supply device using electrolysis, capable of controlling emission amount of a desired gas without causing leakage of an electrolytic solution in an electrolysis tank. The portable gas supply device includes: a battery; a control board for controlling power supply from the battery; a pair of positive/negative electrodes to which power from the battery is supplied or blocked by the control board; an electrolysis tank capable of storing water, into which the pair of positive/negative electrodes are inserted; a permeation device through which only a predetermined gas inside the electrolysis tank can permeate; and a nozzle capable of supplying a gas emitted from the permeation device.

Liquid ventilator and methods integrating the concept of total liquid ventilation (TLV) using liquid volumes below functional residual capacity (FRC) of mammal's lungs are disclosed. Beyond the automatization of the whole process, the technology has been up-scaled to confirm that TLV at residual volumes below FRC can provide a safe procedure while enabling the full potential of TLV in a mammal such as humans or adult-sized animals. Such tidal liquid ventilation strongly differs from the previously known TLV approach, opening promising perspectives for a safer clinical translation. Also disclosed are apparatus and method for safe and fast induction of hypothermia during liquid ventilation of a mammal.

The invention relates to an inhalable gaseous medicament containing argon gas for use in combination with a mechanical thrombectomy for treating, reducing or resorbing brain lesions subsequent to an ischaemic stroke in an individual. Preferably, the proportion by volume of argon is between 30 and 79%. The mechanical thrombectomy can be accompanied by a drug-based thrombolysis to dissolve the clot and to thin the blood of the patient.

Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

Various methods and systems are provided for flushing a medical gas flow system. In one embodiment, a method for a medical gas flow system comprises: performing a disinfecting cycle of a ventilation gas path comprising a plurality of gas flow passages by: flowing gas from a pressurized gas source of the medical gas flow system to a liquid disinfectant reservoir of a flush module; combining the gas with a liquid disinfectant stored within the liquid disinfectant reservoir to form a disinfectant aerosol; and flowing the disinfectant aerosol through the plurality of gas flow passages.

The present invention relates to an insufflator with integrated flue gas extraction. Thanks to a novel valve regulation system, it is possible to direct the gas inflow through two tubes into the body cavity. The novel device also enables an improved pressure control of the body cavity, which leads to lower pressure variations in the body cavity and furthermore compensates higher leakage volume flows.

The present invention relates to an insufflator with integrated flue gas extraction. Thanks to a novel valve regulation system, it is possible to direct the gas inflow through two tubes into the body cavity. The novel device also enables an improved pressure control of the body cavity, which leads to lower pressure variations in the body cavity and furthermore compensates higher leakage volume flows.